PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccine as part of the U.S. Government’s Project NextGen November 14, 2024
Medidata and Bioforum Bolster Decade-Long Relationship to Advance Clinical Data and Biometric Solutions for Clinical Trials November 13, 2024
Novotech Recognized for Excellence in Business Expansion, Innovation, and Marketing at the 2024 Clinical Trials Arena Excellence Awards November 11, 2024
U.S.-Based Shearwater Health Expands to Chennai, Opening New Opportunities for India’s Clinical Talent November 11, 2024
BioIVT LLC and KRISHGEN BioSystems Announce Exclusive Commercial Agreement to Enhance Clinical Research in South Asia November 7, 2024
First patient treated in new phase II clinical trial at Radiumhospitalet in Oslo – promising use of Lytix cancer treatment in patients with early-stage melanoma November 6, 2024
Elicera Therapeutics includes the first patient in the Phase I/II clinical study CARMA targeting B-cell lymphoma November 5, 2024
Common flame retardant chemicals may reduce likelihood of clinical pregnancy, live birth among women undergoing fertility treatments | News November 3, 2024
Biosergen Completes First Cohort of BSG005 Clinical Trial, Shows Promising Potential in Drug-Resistant Fungal Infections October 31, 2024
